Dettmer Susan, Theile Dirk, Seckinger Anja, Burhenne Jürgen, Weiss Johanna
Department of Clinical Pharmacology and Pharmacoepidemiology, Heidelberg University Hospital, D-69120 Heidelberg, Germany.
Department of Internal Medicine V, Oncology, Hematology, and Rheumatology, Heidelberg University Hospital, D-69120 Heidelberg, Germany.
Anal Biochem. 2015 Feb 15;471:23-5. doi: 10.1016/j.ab.2014.10.019. Epub 2014 Nov 4.
Luminescence-based proteasome activity assays use specific substrates that are supposed to be cleaved by cellular proteasome activity leading to luciferase substrates. Usually, control wells containing cell culture medium supplemented with antibiotics and fetal calf serum are used as background. Using the Proteasome-Glo chymotrypsin-like cell-based assay from Promega, we show here that fetal calf sera from different manufacturers contain heat-resistant, bortezomib-inhibitable, chymotrypsin-like activities that can interfere with proteasome activity assays. These data strongly recommend the use of pure phosphate-buffered saline (PBS) or serum-free medium during proteasome activity assays to diminish background luminescence and, thus, to obtain reliable results.
基于发光的蛋白酶体活性测定使用特定底物,这些底物被认为会被细胞蛋白酶体活性切割从而产生荧光素酶底物。通常,含有补充了抗生素和胎牛血清的细胞培养基的对照孔用作背景。使用Promega公司的蛋白酶体 - Glo类胰凝乳蛋白酶样细胞检测法,我们在此表明,不同制造商的胎牛血清含有耐热、硼替佐米可抑制的类胰凝乳蛋白酶样活性,这些活性会干扰蛋白酶体活性测定。这些数据强烈建议在蛋白酶体活性测定过程中使用纯磷酸盐缓冲盐水(PBS)或无血清培养基,以减少背景发光,从而获得可靠的结果。